Patricia Ngai Selected Research

Cyclin D1

12/2007

Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia Ngai Research Topics

Disease

3	Neoplasms (Cancer) 08/2008 - 12/2007
2	Tuberculosis (Tuberculoses) 01/2007 - 04/2006
1	Communicable Diseases (Infectious Diseases) 08/2008
1	Liver Neoplasms (Liver Cancer) 03/2008
1	Infections 05/2007
1	Ischemia 04/2007

Drug/Important Bio-Agent (IBA)

2	VaccinesIBA 08/2008 - 04/2006
1	Caspase 9IBA 12/2007
1	Cisplatin (Platino)FDA LinkGeneric 12/2007
1	Cyclin D1IBA 12/2007
1	SurvivinIBA 12/2007
1	Interferon-gamma (Interferon, gamma)IBA 05/2007
1	AntigensIBA 05/2007
1	CytokinesIBA 05/2007
1	Interleukin-10 (Interleukin 10)IBA 04/2007
1	DNA VaccinesIBA 01/2007

Therapy/Procedure

1	Transplantation 03/2008
1	Therapeutics 03/2008